Provectus Pharmaceuticals, Inc. and Its Subsidiaries Complete Unregistered Offering of Units to Facilitate Spin-off of Pure-ific Corporation

Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, announced today that it and its five wholly owned subsidiaries, Pure-ific Corporation, Provectus Biotech, Inc., Provectus Devicetech, Inc., Provectus Imaging, Inc., and Xantech Pharmaceuticals, Inc. (the "Subsidiaries"), have completed an unregistered offering of Units pursuant to the exemption from registration requirements under Rule 506 of Regulat...continued PVCT  sec pharmaceuticals Healthcare

URL: http://www.investorpoint.com/news/OTCBULLB/47011322/